Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Synthetic Biologics Reports UCLA Announcement of Preliminary Positive Topline Efficacy and Safety Results from Investigator-Led Phase II Study of Trimesta™ for RRMS
The natural history of primary progressive MS in British Columbia, Canada.
T(H)17 cytokines in autoimmune neuro-inflammation.
Gene expression in brain during cuprizone-induced demyelination and remyelination.
Multiple sclerosis in Hispanics: a study of clinical disease expression.
Clinically isolated syndrome - Rethinking the diagnosis.
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.
Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis.
Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID).
[Usefulness of electronic drug registers: Spanish register of patients treated with fingolimod (Gilenya ®)].
IL-17 and Th17 Cells.
Management of worsening multiple sclerosis with mitoxantrone: a review.
Neuroprotection mediated through estrogen receptor-alpha in astrocytes.
Best practice in the use of natalizumab in multiple sclerosis.
The MS Microbiome Consortium (MSMC): an academic multi-disciplinary collaborative effort to elucidate the role of the gut microbiota in MS
Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort.
Therapeutic plasma exchange and pregnancy: A case report and guidelines for performing plasma exchange in a pregnant patient.
Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.
Treatment Choices in Optic Neuritis: Corticosteroids, Intravenous Immunoglobulin, Plasma Exchange, or Other?
Suppressed RNA-Polymerase 1 Pathway Is Associated with Benign Multiple Sclerosis.
Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination.
Teriflunomide modest help but safe for MS
Experimental models of spontaneous autoimmune disease in the central nervous system.

Pages